Menora Mivtachim Holdings Ltd. Red Hill Biopharma Ltd. Transaction History

Menora Mivtachim Holdings Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$6.34 - $8.8 $2.59 Million - $3.6 Million	-409,086 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$6.06 - $9.0 $72,198 - $107,226	-11,914 Reduced 2.83%	409,086 $3.4 Million
Q3 2017 Oct 30, 2017	BUY	$8.25 - $10.81 $3.47 Million - $4.55 Million	421,000	421,000 $4.55 Million

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Menora Mivtachim Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Menora Mivtachim Holdings Ltd. with notifications on news.